Bryn Pharma

Developer of nasal based epinephrine for anaphylaxis

placeRaleigh, North Carolina, United States calendar_todayFounded 2018 groups10 employees language brynpharma.com

Innovation

4 patent families (2 granted) — focus: Human necessities; filing pace slowing. Cited 1,856 times.

YearFilings
20191
20202
20213
20221
20231
20241
20251

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital480%
Private equity120%
Coming soon